PNC Financial Services Group
KDNY

PNC Financial Services Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

PNC Financial Services Group’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-356
Closed -$6K – 4451
2021
Q2 		$6K Hold
356
– – ﹤0.01% 3851
2021
Q1 		$6K Hold
356
– – ﹤0.01% 3794
2020
Q4 		$6K Sell
356
-2
-0.6% -$30 ﹤0.01% 3695
2020
Q3 		$4K Hold
358
– – ﹤0.01% 3736
2020
Q2 		$4K Hold
358
– – ﹤0.01% 3698
2020
Q1 		$4K Hold
358
– – ﹤0.01% 3655
2019
Q4 		$2K Hold
358
– – ﹤0.01% 3822
2019
Q3 		$2K Hold
358
– – ﹤0.01% 3883
2019
Q2 		$2K Hold
358
– – ﹤0.01% 3899
2019
Q1 		$8K Hold
358
– – ﹤0.01% 3656
2018
Q4 		$4K Hold
358
– – ﹤0.01% 3771
2018
Q3 		$14K Hold
358
– – ﹤0.01% 3568
2018
Q2 		$12K Hold
358
– – ﹤0.01% 3635
2018
Q1 		$16K Buy
+358
New +$13.1K ﹤0.01% 3544
2016
Q3 		– Sell
-6
Closed – – 4343
2016
Q2 		$0 Sell
6
-1
-14% -$61 ﹤0.01% 4564
2016
Q1 		$0 Sell
7
-40
-85% -$3.23K ﹤0.01% 4591
2015
Q4 		$7K Buy
47
+8
+21% +$1.09K ﹤0.01% 3753
2015
Q3 		$4K Buy
39
+3
+8% +$357 ﹤0.01% 4066
2015
Q2 		$6K Buy
+36
New +$5.95K ﹤0.01% 4027

Other funds holding KDNY

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PNC Financial Services Group's KDNY Position: Q3 2021 in Review

PNC Financial Services Group sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2021, closing a stake of 356 shares — an estimated $6K sold.

PNC Financial Services Group first reported a position in KDNY in Q2 2015 and held it in 19 quarters. The position peaked at $16K in Q1 2018. 85 funds tracked by Wall St. Rank hold KDNY as of Q3 2021.

  • PNC Financial Services Group reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 356 Chinook Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $6K.
  • PNC Financial Services Group first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 19 quarters.
  • PNC Financial Services Group's Chinook Therapeutics, Inc. Common Stock position peaked at $16K in Q1 2018.
  • 85 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2021.

Based on PNC Financial Services Group's 13F filing for Q3 2021, filed 5 Nov 2021.